To The Moon

📊 Strategy Overview Type: Bull Call Spread (Debit Spread) Structure: Buy-to-Open $44 Call, Sell-to-Open $45 Call (2026-04-17 expiry) Net Debit: $0.46/share (×100 = $46 total cost per spread) 📊 Contracts 🔹 *Buy*: 2026-04-17 $44 Call @ $0.91 (Ask) 🔹 *Sell*: 2026-04-17 $45 Call @ $0.45 (Bid) 📊 Financials Max Profit: $(45 − 44 − 0.46) × 100 = $54 Max Loss: $0.46 × 100 = $46 Break-even: $44.46 at expiry 📊 Thesis Neutral to moderately bullish on $NKE into mid-April, anticipating oversold rebound after stabilization above $42–44 range. IV at ~36% with IV Percentile ~37.6% suggests options are relatively cheap, favoring debit spreads over short-vol structures. Targeting defined risk and balanced Delta exposure. 📊 Risk Management If $NKE closes < $43.50 mid-week, consider cutting/rolling to redu

📋 Contracts Sell to Open: 1x $14.50 Put (2026-04-17) @ $0.24 Bid Buy to Open: 1x $14.00 Put (2026-04-17) @ $0.15 Ask 💰 Financials Credit Received: $0.09/share ($9 per spread) Max Profit: $9 (credit received) Max Loss: $41 (strike width $0.50 − credit $0.09 = $0.41 × 100) Breakeven: $14.41 ($14.50 − $0.09) 📈 Thesis Neutral to moderately bullish on $RIVN into 2026-04-17 expiration. Elevated IV (76.81%, IV Percentile 66%) makes short premium favorable, with a bullish tilt supported by a Call/Put ratio of 1.71. Selling time decay (positive Theta) while keeping downside risk defined. Happy to pocket the $9 credit if $RIVN stays above $14.50, ready to defend if it doesn’t. 🛠️ Execution Plan Profit Target: Close at 50–75% of max profit ($5–$7) within a few days if achieved. Risk Management: Exit

Contracts: Sell to Open {{SHORT_LEG}} Buy to Open {{LONG_LEG}} Financials: Credit Received: Max Gain: (Credit received) Max Loss: (Strike width - Credit received) Thesis: Neutral to moderately {{MARKET_VIEW}} on $PEP into {{EXPIRATION_DATE}} expiration. Selling {{TIME_FRAME}} premium while defining {{RISK_MANAGEMENT}} risk. Happy to pocket the credit if $PEP stays {{THESIS_CONDITION}}, ready to defend if it doesn't. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. X 📊 $PEP Bull Call Spread 04/17 Buy $157.5C|Sell $160C Cost:$137|Max:$113|Loss:$137 BE:$158.87 Neutr

Contracts Buy to Open: 1x $GE 2026-04-17 $305 Call @ $12.20 ask Sell to Open: 1x $GE 2026-04-17 $315 Call @ $5.475 bid Financials Net Debit: $12.20 − $5.475 = $6.725/share ($672.50 per spread) Max Gain: ($10 strike width − $6.725 debit) × 100 = $327.50 Max Loss: $6.725 × 100 = $672.50 Thesis Neutral to moderately bullish on $GE into April expiration. Current price near $313.02 suggests upward consolidation or range-holding above $312. Elevated IV (41.79%, 92.8th percentile) favors a defined-risk structure with mild short vega exposure. Breakeven at $311.725 improves odds slightly below spot. Execution Plan Profit Target: Close for $2.50–$3.00 credit (~75–90% max gain) Stop Loss: Exit if $GE drops < $305 or spread loses ~50% cost (~$335). Time Rule: Exit early if $GE ≥ $315 with >2 da

📊 Strategy Overview Underlying: $BAC (currently trading at $52.71) Market View: Moderately bullish on BAC with elevated implied volatility (IV ~73%). Looking to capture upside while capping risk and reducing Vega exposure versus a long call. 📄 Contracts (2026-04-17 Expiry) Buy to Open: 1× $52 Call @ $1.66 Sell to Open: 1× $53 Call @ $1.04 💰 Financials Net Debit (Cost): $62/spread (calculated as $166 - $104) Max Profit: $38/spread (Strike Width $100 - Net Debit $62) Max Loss: $62/spread (Net Debit paid) 📈 Thesis Neutral to moderately bullish on $BAC into April 2026 expiration. This debit spread reduces Vega exposure (IV/HV ~1.56) while maintaining a positive Delta for upside participation. Short call premium offsets some time decay (Theta), making this more efficient than a naked long call.

$TripAdvisor(TRIP)$ Tripadvisor (TRIP) Jumps +5.12%: Momentum Builds as DIF Crosses into Positive Territory, Eyeing $13.21 Latest Close Data: As of April 9, 2026, TRIP closed at $11.49, surging +5.12% (+$0.56). The stock is trading -43.0% below its 52-week high of $20.16. Core Market Drivers: The move appears driven by a combination of positive technical momentum and a favorable valuation narrative. While no major company-specific news was highlighted today, the stock's low P/E relative to its historical average and a recent shift in short-term capital flows (net inflows over the last two days) may be contributing to the buying interest. Technical Analysis: The rally was supported by above-average net capital inflow ($3.77M). Crucially, the MACD (

In this Elliott Wave update, Meta Platforms Inc. ($META) is being revisited following the previously discussed blue box support areas. As anticipated, the reaction from those areas has happened as expected. Buying interest was seen from the blue box zones, and a meaningful bounce has been produced. As a result, the bullish sequence has been respected, and further upside is now being allowed while the stock remains above the key invalidation level. $META Reaction From the Blue Box Areas Has Been Confirmed $META In the prior outlook, attention was drawn to the blue box area as high-frequency support zones where the correction was expected to be completed and buyers were expected to step in. That view has now been validated by price action. A strong reaction was produced from the blue bo